Target intelligence / Profile preview

Mixed oral plaque bacteria and volatile sulfur compound precursors

Molecular classification
Other
01

Overview

Mixed oral plaque bacteria and volatile sulfur compound (VSC) precursors represent a complex biological target system primarily associated with oral malodor and periodontal health. The target consists of anaerobic Gram-negative bacteria, such as Porphyromonas gingivalis, Treponema denticola, and Prevotella intermedia, which reside within the dental plaque biofilm (Source: PubMed PMID: 15752094). These microorganisms utilize proteolytic enzymes to metabolize sulfur-containing amino acids—specifically cysteine and methionine—found in saliva and food debris (Source: PubMed PMID: 24564061). This metabolic process results in the production of VSCs, including hydrogen sulfide and methyl mercaptan, which are the principal components of halitosis. Therapeutic strategies targeting this system involve the use of antiseptic agents to reduce bacterial density and metal ions, like zinc, which inhibit the enzymatic breakdown of precursors or chemically neutralize the resulting gases (Source: PubMed PMID: 12787205). Effective management of this target is essential for both cosmetic breath control and the prevention of inflammatory oral diseases.

Other names
Oral biofilmDental plaqueVSC precursorsHalitosis-associated microbiotaSulfur-producing oral bacteria
02

Mechanism of action

Antimicrobial agents reduce the total load of anaerobic bacteria; metal ions (e.g., Zinc) bind to thiol groups of precursors to prevent conversion or directly neutralize VSCs; oxidizing agents convert VSCs into non-volatile forms.

03

Biological functions

MetabolismBiofilm formationProteolysisAnaerobic respiration
04

Disease associations

HalitosisPeriodontal diseaseGingivitisInfection
05

Safety considerations

Disruption of the natural oral microbiomeExtrinsic tooth staining (e.g., from chlorhexidine)Dysgeusia (taste disturbance)Oral mucosal irritationDevelopment of antimicrobial resistance
06

Interacting drugs

Chlorhexidine

8 more in the full profile.

07

Biomarkers

Hydrogen sulfide levelsMethyl mercaptan levelsDimethyl sulfide levelsPlaque indexBacterial colony forming units (CFU)

Beyond the preview

Go deeper on Mixed oral plaque bacteria and volatile sulfur compound precursors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mixed oral plaque bacteria and volatile sulfur compound precursors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call